The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases

[1]  Chicago Consensus Working Group,et al.  The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations , 2020 .

[2]  Chicago Consensus Working Group,et al.  The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors , 2020 .

[3]  Chicago Consensus Working Group.  The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors , 2020 .

[4]  Chicago Consensus Working Group,et al.  The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms , 2020 .

[5]  Chicago Consensus Working Group,et al.  The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma , 2020 .

[6]  Chicago Consensus Working Group,et al.  The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases , 2020 .

[7]  Chicago Consensus Working Group,et al.  The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms , 2020 .

[8]  Chicago Consensus Working Group,et al.  The Chicago Consensus on Peritoneal Surface Malignancies: Standards , 2020 .

[9]  Chicago Consensus Working Group,et al.  The Chicago Consensus on Peritoneal Surface Malignancies: Methodology , 2020 .

[10]  Chicago Consensus Working Group,et al.  The Chicago Consensus Guidelines for Peritoneal Surface Malignancies: Introduction , 2020 .

[11]  R. Yantiss,et al.  The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors , 2020, Annals of Surgical Oncology.

[12]  N. Ahuja,et al.  The Chicago Consensus Guidelines for peritoneal surface malignancies: Introduction , 2020, Cancer.

[13]  R. Yantiss,et al.  The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations , 2020, Cancer.

[14]  S. Msika,et al.  Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[16]  J. Ajani,et al.  Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma , 2017, Annals of Surgical Oncology.

[17]  S. Hahn,et al.  Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. , 2016, The Lancet. Oncology.

[18]  J. Yu,et al.  Staging laparoscopy improves treatment decision-making for advanced gastric cancer. , 2016, World journal of gastroenterology.

[19]  P. Sugarbaker,et al.  Comprehensive treatment for the peritoneal metastasis from gastric cancer , 2015 .

[20]  P. Piso,et al.  Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  A. Königsrainer,et al.  Initial Clinical Experience with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Signet-Ring Cell Gastric Cancer with Peritoneal Metastases , 2014, Journal of gastric cancer.

[22]  V. Lemmens,et al.  No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  A. Ohtsu,et al.  Randomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106). , 2013, Japanese Journal of Clinical Oncology.

[24]  A. Ohtsu,et al.  Randomized Phase III Study of 5-Fluorouracil Continuous Infusion vs . Sequential Methotrexate and 5-Fluorouracil Therapy in Far Advanced Gastric Cancer with Peritoneal Metastasis ( JCOG 0106 ) , 2013 .

[25]  Y. Yonemura,et al.  Surgical Results of Patients with Peritoneal Carcinomatosis Treated with Cytoreductive Surgery Using a New Technique Named Aqua Dissection , 2012, Gastroenterology research and practice.

[26]  Yan Li,et al.  Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial , 2011, Annals of Surgical Oncology.

[27]  Yoon-Koo Kang,et al.  Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial , 2010, The Lancet.

[28]  L. Jacks,et al.  Comparison of Gastric Cancer Survival Following R0 Resection in the United States and Korea Using an Internationally Validated Nomogram , 2010, Annals of surgery.

[29]  E. Cotte,et al.  Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy , 2010, Annals of Surgical Oncology.

[30]  C. Iancu,et al.  Staging laparoscopy in gastric cancer. Accuracy and impact on therapy. , 2009, Journal of gastrointestinal and liver diseases : JGLD.

[31]  T. Kawamura,et al.  Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion , 2005, The British journal of surgery.

[32]  Takuma Sasaki,et al.  Effective therapy for peritoneal dissemination in gastric cancer. , 2003, Surgical oncology clinics of North America.

[33]  K. Geisinger,et al.  Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. , 2003, Archives of surgery.

[34]  H. Kitagawa,et al.  Diagnostic Laparoscopy, Serum CA125, and Peritoneal Metastasis in Gastric Cancer , 2002, Endoscopy.

[35]  T. Yoshikawa,et al.  Is gastric carcinoma different between Japan and the United States? , 2000, Cancer.